Asian Journal of Pharmaceutical Sciences

作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况；生成式人工智能及AI辅助技术可为研究和学术出版提供显著益处，但绝不能替代人类的批判性思维、专业知识和评估，且只能在人类监督和控制下使用。 模型中文摘要

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper. Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use. Authors preparing a manuscript for this journal may use AI to…

所有作者均应在研究设计或数据获取、数据分析或解释、起草或批判性修改稿件以及最终批准提交版本方面做出实质性贡献，并对工作的所有方面负责，以确保与工作任何部分的准确性或完整性相关的问题得到适当调查和解决。 模型中文摘要

All authors should have made substantial contributions to all of the following: The conception and design of the study, or acquisition of data, or analysis and interpretation of dataDrafting the article or revising it critically for important intellectual content.Final approval of the version to be submitted. All authors are accountable for all aspects of the work, to ensure that questions related…

所有作者必须披露任何可能不当影响或偏袒其工作的财务和个人关系，包括雇佣、咨询、持股、酬金、有偿专家证言、专利申请或注册、资助或其他资金，以及与期刊作为编辑或顾问委员会成员的隶属关系。 模型中文摘要

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include: EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board…

该许可允许用户分发和复制文章，并将其纳入合集作品（如选集），但仅限非商业目的，且用户须给予作者适当署名（通过相关DOI链接至正式出版物）、提供许可链接，且不得更改或修改文章；如需遵守资助机构政策，可在稿件被接受后申请CC BY许可。 模型中文摘要

Allows users to: distribute and copy the article; and include in a collective work (such as an anthology). These uses are permitted only for non-commercial purposes, and provided the user: gives appropriate credit to the author(s) (with a link to the formal publication through the relevant DOI); provides a link to the license; and does not alter or modify the article. If you need to comply with yo…

这是一本开放获取期刊：所有文章将立即且永久免费供所有人阅读和下载；为提供开放获取，该期刊收取开放获取费用（也称文章出版费APC），需由作者或其代表（如研究资助者或机构）支付；允许的第三方（再）使用由Creative Commons用户许可定义。 模型中文摘要

This is an open access journal: all articles will be immediately and permanently free for everyone to read and download. To provide open access, this journal has an open access fee (also known as an article publishing charge APC) which needs to be paid by the authors or on their behalf e.g. by their research funder or institution. Permitted third party (re)use is defined by the following Creative …

该期刊遵循双盲同行评审流程；投稿将首先由编辑评估是否适合在该期刊发表，如被认为合适，通常会送至少两名审稿人进行独立的专家评估，接受或拒绝的决定由编辑做出，且该决定为最终决定。 模型中文摘要

This journal follows a double anonymized review process. Your submission will initially be assessed by our editors to determine suitability for publication in this journal. If your submission is deemed suitable, it will typically be sent to a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected will…

提交至KeAi期刊的稿件会在编辑系统内自动使用iThenticate的CrossCheck进行筛查，以检测抄袭问题，包括提交稿件中重叠和相似文本的情况。 模型中文摘要

Submissions to KeAi journals are automatically screened using iThenticate's CrossCheck within the editorial system to detect plagiarism issues including instances of overlapping and similar text in submitted manuscripts.

作者可按照Elsevier的文章分享政策分享预印本；在预印本服务器等平台分享预印本不会被视为先行发表。 模型中文摘要

Authors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication. We advise you to read our policy on multiple, redundant or concurrent publication.